GSK
GSK tops drug approval rates
March 7, 2014Medical Communications, Sales and Marketing FDA, GSK, J&J, JJ, Merck, Sanofi, ep, evaluate pharma, lilly, nme
GlaxoSmithKline is riding high when it comes to the approval of new medicines but US firm Lilly is falling behind. …
GSK submits new Promacta licence
March 3, 2014Sales and Marketing GSK, NICE, Promacta, Revolade, blood, eltrombopag
GlaxoSmithKline is seeking a new licence for its blood disorder drug Promacta in patients with severe aplastic anaemia. Specifically, the …
GSK’s Witty loses bonus over China scandal
February 28, 2014Medical Communications, Sales and Marketing China, GSK, Witty, sales, sir andrew
GlaxoSmithKline’s chief executive Sir Andrew Witty received bonuses “lower than they otherwise might have been” last year due to the …
CHMP breathes new life into GSK, Teva and Novartis
February 24, 2014Research and Development, Sales and Marketing CHMP, COPD, EMA, GSK, Gilead, Teva, asthma, onoro
The CHMP has given its backing to a number of new treatments for respiratory diseases, which include two from London-based …
GSK/Theravance lung drug bags CHMP approval
February 21, 2014Sales and Marketing CHMP, COPD, GSK, Theravance, anoro
The CHMP has given its backing to GlaxoSmithKline and partner Theravance’s new chronic obstructive pulmonary disease medicine Anoro. The treatment …
GSK starts rare blood trial
February 18, 2014Research and Development, Sales and Marketing GSK, blood, mepolizumab
GlaxoSmithKline has begun a Phase III study to look at mepolizumab in a rare condition characterised by vasculitis – widespread …
Pharma’s reputation ‘getting worse’
February 17, 2014Medical Communications, Sales and Marketing GSK, Gilead, Pfizer, ViiV, patientview, pharma, reputation
The pharma industry’s reputation is getting worse – at least, in the eyes of 800 patient groups – according to …
GSK to make ‘fundamental changes’
February 6, 2014Sales and Marketing China, GSK, Tafinlar, Witty, q4, results
GlaxoSmithKline has pledged to make ‘fundamental changes’ to the manner in which it does business, looking at its interaction with …
Drug giants team up for Alzheimer’s
February 5, 2014Research and Development, Sales and Marketing Accelerating Medicines Partnership, Alzheimer's, Alzheimer’s, GSK, Merck, National Institutes of Health, Pfizer
The top US medical research agency has brought together a ‘dream team’ of big pharma partners to help battle against …
GSK halts chickenpox vaccines over quality concerns
January 29, 2014Manufacturing and Production, Sales and Marketing Boostrix-Polio, GSK, Varilrix, chickenpox, vaccines
GlaxoSmithKline has suspended worldwide distribution of two chickenpox vaccines after production standards were not met at one of its facilities …
GSK has Tafinlar ‘breakthrough’
January 15, 2014Sales and Marketing Cancer, FDA, GSK, NSCLC, Tafinlar
GlaxoSmithKline is on a roll, with its cancer drug Tafinlar given breakthrough therapy designation by the FDA in lung cancer …
FDA approves GSK cancer combo
January 14, 2014Research and Development, Sales and Marketing FDA, GSK, Tafinlar, mekinist
US regulators have shown the green light to a combination of two GlaxoSmithKline skin cancer drugs, Mekinist and Tafinlar, to …
GSK makes imaging deal
January 14, 2014Manufacturing and Production, Sales and Marketing 3D, GSK, imaging, npl
GlaxoSmithKline has signed a deal with the National Physical Laboratory (NPL) to develop an imaging system which can show for …
GSK and Sanofi expand transparency
January 6, 2014Research and Development, Sales and Marketing GSK, Goldacre, Sanofi, alltrials, transparency
GlaxoSmithKline and Sanofi have announced separate moves which will shine greater light on both companies’ clinical trial data. GSK has …
GSK sells off non-core assets
January 6, 2014Sales and Marketing GSK, Suntory, aspen, lucozade, ribena
GlaxoSmithKline has completed the offloading of several of its non-core assets in moves which stand to net the pharma manufacturer …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
